Effect of African-American race and hypertensive left ventricular hypertrophy on coronary vascular reactivity and endothelial function

Hypertension

Volumn 29, Issue 3, 1997, Pages 706-714

  Houghton, Jan Laws ^a   Smith, Vivienne E ^a   Strogatz, David S ^b   Henches, Nancy L ^a   Breisblatt, Warren M ^a   Carr, Albert A ^c  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c Albany Medical College ^*

Author keywords

blacks; endothelial function; hypertrophy, left ventricular; race; vascular reactivity; vasorelaxation

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; VASODILATOR AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SUBLINGUAL DRUG ADMINISTRATION; THORAX PAIN; VASCULAR ENDOTHELIUM;

EID: 0031037169     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.3.706     Document Type: Article

References (41)

1. Cooper ES, Celer LH, Saunders E, Martinez-Maldonado M, Caplan LR, Yatsu FM, Savage DD, Curry CL, Yu PN, Shulman NB. Cardiovascular diseases and stroke in African Americans and other racial minorities in the United States: a statement for health professionals. Circulation. 1991;83:1462-1480.
2. Gillum RF. Cardiovascular disease in the United States: an epidemiologic overview. In: Saunders E, ed. Cardiovascular Diseases in Blacks. Philadelphia, Pa: FA Davis; 1991:1-16.
3. Freedman DS, Gruchow H, Manley JC, Anderson A, Sobocinski K, Barboriak J. Black/white differences in risk factors for arteriographically documented coronary artery disease in men. Am J Cardiol. 1988;62:214-219.
4. Sempos C, Cooper R, Kovar M, McMillen M. Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health. 1988;78:1422-1427.
5. Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J, Kubler W. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation. 1984;69:1-7.
6. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol. 1990;15:43-51.
7. Houghton JL, Prisant LM, Carr AA, von Dohlen TW, Frank MJ. Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease. Am Heart J. 1991;121:1107-1112.
8. Houghton JL, Carr AA, Prisant LM, Rogers WB, von Dohlen TW, Flowers NC, Frank MJ. Morphologic, hemodynamic, and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia. Am J Cardiol. 1992;69:219-224.
9. Gorlin R. Hypertension and ischemic heart disease: the challenge of the 1990's. Am Heart J. 1991;121:658-664.
10. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;299:373-376.
11. Treasure CB, Klein L, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993; 87:86-93.
12. Blendon RJ, Aiden LH, Freeman HE, Corey CA. Access to medical care for black and white Americans: a matter of continuing concern. JAMA. 1989;261:278-281.
13. Oberman A, Cutta G. Issues in the natural history and treatment of coronary heart disease in black populations: surgical treatment. Am Heart J. 1984;108:688-694.
14. Liu K, Cedres LB, Stamler J, Dyer A, Stamler R, Nanas S, Berkson DM, Oglesby P, Lepper M, Lindberg HA, Marquardt J, Stevens E, Schoenberger JA, Shekelle RB, Collette P, Garside D. Relationship of education to major risk factors and death from coronary heart disease, cardiovascular diseases and all causes. Circulation. 1982;66:1308-1314.
15. Hypertension Detection and Follow-up Program Cooperative Group. Race, education, and prevalence of hypertension. Am J Epidemiol. 1977;106:351-361.
16. Hildreth C, Saunders E. Hypertension in blacks: climcal overview. In: Saunders E, ed. Cardiovascular Diseases in Blacks. Philadelphia, Pa: FA Davis; 1991:85-96.
17. Harris M, Hadden W, Knowler W, Bennett P. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes. 1987;36:523-534.
18. Houghton JL, Prisant LM, Carr AA, Flowers NC, Frank MJ. Racial differences in myocardial ischemia and coronary flow reserve in hypertension. J Am Coll Cardiol. 1994;23:1123-1129.
19. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO III. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence for a generalized endothelial abnormality. J Am Coll Cardiol. 1994;23:274A. Abstract.
20. Troy BC, Pombo J, Rackley C. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45: 602-611.
21. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
22. Levy D, Savage D, Garrison R, Anderson D, Kannell W, Castelli W. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;59:956-960.
23. DeSimone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JL. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056-1062.
24. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994;23:833-843.
25. Luscher T, Boulanger CM, Dohi Y, Zang Z. Endothelium derived contracting factors. Hypertension. 1992;19:117-130.
26. Antony I, Nitenberg A, Foult JM, Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol. 1993;22:514-520.
27. Brush J, Faxon D, Salmon S, Jacobs A, Ryan T. Abnormal endothelium dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 1992;19:809-815.
28. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471-476.
29. Creager M, Cooke J, Mendelsohn M. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
30. Drexler H, Zeiher A, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1550.
31. Zeiher A, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
32. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987;80:1808-1811.
33. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 1994;73:951-952.
34. Vita J, Treasure C, Nabel E. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
35. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez AG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol. 1993;22:642-647.
36. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, Fischer C, De Maria AN. Intravascular ultrasound assessment of human size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84:1087-1099.
37. Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis. 1988;30:349-380.
38. Drayer JM, Gardin JM, Brewer DD, Weber MA. Disparate relationships between blood pressure and left ventricular mass in patients with and without left ventricular hypertrophy. Hypertension. 1987;9(suppl II):II-61-II-64.
39. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:550-558.
40. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation. 1990;82:1595-1606.
41. Egashira S, Tomoike H, Nishijima H, Adachi H, Nakamura M. Effects of ionic and nonionic contrast media on coronary diameter and blood flow in chronically instrumented dogs. Am Heart J. 1989;118:39-46.